10x Genomics (TXG) Other Operating Expenses (2018 - 2025)

10x Genomics (TXG) has 6 years of Other Operating Expenses data on file, last reported at -$40.7 million in Q2 2025.

• For the quarter ending Q2 2025, Other Operating Expenses changed N/A year-over-year to -$40.7 million; the trailing twelve-month figure through Mar 2026 stood at -$40.7 million (down 342.39% YoY), and the FY2025 full-year result was -$49.9 million, changed N/A from the prior year.
• Other Operating Expenses slipped to -$40.7 million in Q2 2025, from -$9.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $41.4 million in Q3 2023 to a low of -$40.7 million in Q2 2025.
• A 3-year average of $1.7 million and a median of -$330000.0 in 2021 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 37.09% in 2021, while the deepest fall reached 363.98% in 2021.
• Tracing TXG's Other Operating Expenses over 3 years: stood at -$850000.0 in 2021, then jumped by 2403.29% to $19.6 million in 2023, then slumped by 307.89% to -$40.7 million in 2025.
• Business Quant data shows TXG's Other Operating Expenses at -$40.7 million in Q2 2025, -$9.2 million in Q1 2025, and $19.6 million in Q4 2023.